Mark Uden

Title: Mark Uden: Innovator in Cell Isolation and Antibody Development

Introduction

Mark Uden is a prominent inventor based in London, GB, known for his contributions to the fields of cell isolation and antibody development. With a total of 2 patents, Uden has made significant strides in advancing medical technologies that have the potential to improve therapeutic outcomes.

Latest Patents

Uden's latest patents include innovative methods for isolating and expanding cells. One of his notable inventions is a method for the isolation of lymphocytes, particularly γδ T cells, from non-haematopoietic tissue samples. This method involves culturing a biopsy in the presence of Interleukin-2 (IL-2) and Interleukin-15 (IL-15), leading to the collection of a population of lymphocytes. Additionally, he has developed multispecific anti-TCR delta variable 1 antibodies, which consist of a Fab region specific for an epitope of the variable delta 1 (Vδ1) chain of a γδ T cell receptor and an Fc region with an EGFR binding site. These inventions also encompass compositions and methods of treatment involving these multispecific antibodies.

Career Highlights

Throughout his career, Uden has worked with notable companies such as Gammadelta Therapeutics Ltd and F-star Therapeutics, Inc. His work in these organizations has allowed him to further his research and development in the field of immunotherapy.

Collaborations

Uden has collaborated with several professionals in his field, including Mihriban Tuna and Joshua Freedman. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Mark Uden's innovative work in cell isolation and antibody development showcases his commitment to advancing medical science. His contributions have the potential to significantly impact therapeutic practices in the future.